Purple Biotech Ltd. Share Price
NASDAQ: PPBTPurple Biotech Ltd. Stock Performance
Purple Biotech Ltd. Share Price Today
As of 30 October 2026, Purple Biotech Ltd.'s share price is $1.10. The stock opened at $1.10, compared to its previous close of $1.09. During today's trading session, Purple Biotech Ltd.'s share price traded between $1.10 and $1.10, with an average price of $1.10. Over the past 52 weeks, the stock has recorded a high of $5.10 and a low of $0.42. In terms of performance, Purple Biotech Ltd.'s share price has declined by 74.60% over the last six months and is up 40.13% on a year-on-year basis.
Purple Biotech Ltd. Share Price Chart
About Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
Purple Biotech Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.48 | $1.10 | -24.14% |
Sep 2026 | $1.48 | $1.45 | -14.71% |
Aug 2026 | $1.44 | $1.70 | +18.88% |
Jul 2026 | $1.71 | $1.43 | -15.63% |
Jun 2026 | $2.13 | $1.70 | -41.45% |
May 2026 | $3.83 | $2.90 | -33.14% |
Apr 2026 | $4.25 | $4.33 | +10.60% |
Mar 2026 | $4.72 | $3.92 | +785.75% |
Feb 2026 | $0.57 | $0.44 | -23.79% |
Jan 2026 | $0.70 | $0.58 | -9.94% |
Dec 2025 | $0.81 | $0.64 | -19.70% |
Nov 2025 | $0.79 | $0.80 | +2.17% |